Novartis says EU has approved best-selling hypertension drug …
Novartis: EU approves Diovan for childrenGENEVA — Pharmaceutical maker Novartis AG said Friday the European Union has approved its best-selling hypertension drug Diovan for treatment of children aged 6-18.
View full post on hypertension – Google Blog Search
Loading...







